Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M145Revenue $M0.5Net Margin (%)--Altman Z-Score22.0
Enterprise Value $M85.3EPS $-0.2Operating Margin %--Piotroski F-Score4
P/E(ttm)--Beneish M-Score-3.2Pre-tax Margin (%)--Higher ROA y-yY
Price/Book2.310-y EBITDA Growth Rate %-3.9Quick Ratio27.0Cash flow > EarningsY
Price/Sales--5-y EBITDA Growth Rate %-10.9Current Ratio27.0Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-30.0Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-34.2Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M82.8ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with CPRX

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

CPRX is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


CPRX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Miller SteveCOO 2016-01-11Buy7,933$1.8-7.22view
O'Keeffe Charles BDirector 2016-01-08Buy5,000$1.94-13.92view
DENKHAUS DONALD ADirector 2016-01-07Buy25,000$2.03-17.73view
MCENANY PATRICK JPresident and CEO 2015-12-28Buy25,000$2.39-30.13view
O'Keeffe Charles BDirector 2015-12-23Buy5,000$2.41-30.71view
O'Keeffe Charles BDirector 2015-11-19Buy5,000$2.3-27.39view
Winship M DouglasVP, Regulatory Operations 2015-10-23Sell22,800$3.34-50view
O'Keeffe Charles BDirector 2015-10-01Buy10,000$2.85-41.4view
MCENANY PATRICK JPresident and CEO 2015-10-01Buy10,000$2.81-40.57view
MUTH DAVID DEVP, Chief Commercial Officer 2015-05-01Buy1,700$3.2-47.81view

Quarterly/Annual Reports about CPRX:

    News about CPRX:

    Articles On GuruFocus.com
    Catalyst Pharmaceuticals Insider Picks Up Shares of Company Oct 05 2015 
    Piper Jaffray Remains Bullish on Catalyst Pharmaceuticals Following the Close of its Recent Public O Feb 17 2015 
    Weekly CEO Buys Highlight: BH, CLMS, OPK, GPC, CPRX Jan 18 2015 
    Weekly CEO Buys Highlight: BH, CLMS, OPK, CPRX, BRT Jan 12 2015 
    Largest Insider Buys of the Week Oct 25 2013 
    Weekly CFO Buys Highlight: CPRX, APPY, MEI, MNKD Jul 09 2012 
    Weekly CFO Buys Highlight: EMC, DVOX, NANX, CPRX, CCRN Jun 04 2012 
    Catalyst Pharmaceutical Partners Inc. Reports Operating Results (10-Q) Nov 15 2010 
    Catalyst Pharmaceutical Partners Inc. Reports Operating Results (10-Q) Aug 12 2010 
    Catalyst Pharmaceutical Partners Inc. (CPRX) CEO Patrick J Mcenany buys 9,359 Shares Jun 16 2010 

    More From Other Websites
    CATALYST PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Feb 08 2016
    8:04 am Catalyst Pharma initiates an investigator-sponsored trial of Firdapse; anticipates reporting... Feb 08 2016
    Catalyst Pharmaceuticals Announces Initiation of Investigator-Sponsored Study of Firdapse in... Feb 08 2016
    Catalyst Pharmaceuticals to Present at the 18th Annual BIO CEO & Investor Conference Feb 04 2016
    Insider Buying Points To Huge Upside For These 3 Beaten-Down Stocks Jan 13 2016
    CATALYST PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Dec 17 2015
    Catalyst Pharmaceuticals Completes NDA Submission to FDA for Firdapse for the Treatment of... Dec 17 2015
    A Change in Tides - Analyst Notes on Hemisphere Media Group, AngioDynamics, ChemoCentryx and... Dec 17 2015
    Catalyst Pharmaceuticals Announces Top-Line Results in Phase 1(b) Trial of CPP-115 Dec 16 2015
    CATALYST PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Dec 16 2015
    Catalyst Pharmaceuticals Announces Top-Line Results in Phase 1(b) Trial of CPP-115 Dec 16 2015
    CATALYST PHARMACEUTICALS, INC. Financials Dec 08 2015
    Hedge Funds Are Dumping Catalyst Pharmaceutical Partners, Inc. (CPRX) Nov 25 2015
    Catalyst Pharmaceuticals to Present at the 27th Annual Piper Jaffray Healthcare Conference Nov 23 2015
    Beyond the Chart, What Price Data Reveals - Research on Endochoice Holdings, Catalyst... Nov 19 2015
    ArQule's Drug Gets Orphan Drug Status for Proteus Syndrome Nov 18 2015
    Catalyst Pharmaceuticals' Q3 Loss Narrower than Expected Nov 10 2015
    CATALYST PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Nov 09 2015
    Catalyst Pharmaceuticals Announces Third Quarter 2015 Financial Results and Provides Corporate... Nov 09 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK